☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
AstraZeneca
AstraZeneca Reports the EMA’s Acceptance of MAA for Sipavibart Under Accelerated Assessment to Prevent COVID-19
July 1, 2024
AstraZeneca’s Tagrisso Plus Chemotherapy Receives NMPA’s Approval to Treat EGFR-Mutated Advanced Lung Cancer
June 27, 2024
AstraZeneca’s Tagrisso Plus Chemotherapy Receives Japanese Approval to Treat EGFR-Mutated Advanced Lung Cancer
June 26, 2024
AstraZeneca Reports Updated Data from the P-III (ADJUVANT BR.31) Study of Imfinzi to Treat Non-Small Cell Lung Cancer
June 25, 2024
AstraZeneca’s Truqap in Combination with Faslodex Receives EC’s Approval for Treating Breast Cancer
June 20, 2024
AstraZeneca Reports Data from the P-III (CAPItello-290) Study of Truqap Combined with Chemotherapy to Treat Triple-Negative Breast...
June 19, 2024
Load more...
Back to Home